| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.4 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.4 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |